Publications by authors named "James Dignam"

Claim this Profile
P
Phase 3 Trial of Dose-Escalated Radiation Therapy and Standard Androgen Deprivation Therapy Versus Dose-Escalated Radiation Therapy and Enhanced Androgen Deprivation Therapy With Orteronel for Men With High-Risk Prostate Cancer (NRG/RTOG 1115).
Daniel A Hamstra, James J Dignam, Deborah W Bruner, M Dror Michaelson, François Bachand

Int J Radiat Oncol Biol Phys· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Docetaxel with Androgen Deprivation and Radiotherapy in High-risk Localized Prostate Cancer: An ICECaP Individual Patient Data Meta-analysis.
Praful Ravi, Lucia Kwak, Wanling Xie, Anthony D'Amico, James Dignam

Eur Urol Oncol· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Duration of Androgen Suppression with Postoperative Radiotherapy (DADSPORT) for Nonmetastatic Prostate Cancer: A Collaborative Systematic Review and Meta-analysis of Aggregate Data.
Sarah Burdett, David J Fisher, Jayne F Tierney, Adrian D Cook, Daniel E Spratt, James J Dignam

Eur Urol· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Dual Immune Check Point Blockade in -Unmethylated Newly Diagnosed Glioblastoma: NRG Oncology BN007, a Randomized Phase II/III Clinical Trial.
Andrew B Lassman, Mei-Yin C Polley, Fabio M Iwamoto, Andrew E Sloan, Tony J C Wang, James J Dignam

J Clin Oncol· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Validation of a Longitudinal Marker as a Surrogate Using Mediation Analysis and Joint Modeling: Evolution of the PSA as a Surrogate of the Disease-Free Survival.
Quentin Le Coent, Catherine Legrand, James J Dignam, Virginie Rondeau

Biom J· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
On the use of external controls in clinical trials.
Michelle M Nuño, Stephanie L Pugh, Lingyun Ji, Jin Piao, James J Dignam

J Natl Cancer Inst Monogr· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
The importance of patient-centered research in oncology clinical trials: motivation for the Monograph series.
Stephanie L Pugh, Cecilia Lee, Barbara K Dunn, James J Dignam

J Natl Cancer Inst Monogr· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Design and analysis considerations for investigating patient subgroups of interest within cancer clinical trials.
Gina L Mazza, Eva Culakova, Danielle M Enserro, James J Dignam, Joseph M Unger

J Natl Cancer Inst Monogr· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Refining Risk Stratification of High-risk and Locoregional Prostate Cancer: A Pooled Analysis of Randomized Trials.
Praful Ravi, Wanling Xie, Marc Buyse, Susan Halabi, Philip W Kantoff, James Dignam

Eur Urol· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Scaling and interpreting treatment effects in clinical trials using restricted mean survival time.
Theodore Karrison, Chen Hu, James Dignam

Clin Trials· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Summary from the NCI clinical trials planning meeting on next generation of clinical trials in non-muscle invasive bladder cancer.
Andrea Apolo, Brian C Baumann, Hikmat Al-Ahmadie, Leslie Ballas, Rick Bangs, James J Dignam

Bladder Cancer· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Prognostic factors in post-prostatectomy salvage radiotherapy setting with and without hormonotherapy: An individual patient data analysis of randomized trials from ICECaP database.
Pascal Pommier, Wanling Xie, Praful Ravi, Christian Carrie, James J Dignam

Radiother Oncol· December 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Ten challenges and opportunities in computational immuno-oncology.
Riyue Bao, Alan Hutson, Anant Madabhushi, Vanessa D Jonsson, Spencer R Rosario, James Dignam

J Immunother Cancer· October 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Long-Term Analysis of NRG Oncology RTOG 0415: A Randomized Phase III Noninferiority Study Comparing Two Fractionation Schedules in Patients With Low-Risk Prostate Cancer.
W Robert Lee, James J Dignam, Mahul B Amin, Deborah W Bruner, Daniel Low

J Clin Oncol· July 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Leveraging external control data in the design and analysis of neuro-oncology trials: Pearls and perils.
Mei-Yin C Polley, Daniel Schwartz, Theodore Karrison, James J Dignam

Neuro Oncol· May 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Risk Factors for Hospital Readmission in Patients With Interstitial Lung Disease.
Cathryn T Lee, Kavitha Selvan, Ayodeji Adegunsoye, Rachel K Strykowski, William F Parker, James J Dignam

Respir Care· April 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cardiovascular Mortality and Duration of Androgen Deprivation in Locally Advanced Prostate Cancer: Long-term Update of NRG/RTOG 9202.
Kimberley S Mak, Molly Scannell Bryan, James J Dignam, William U Shipley, Yue Lin

Eur Urol Focus· March 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Early Endpoints in High-risk Localized Prostate Cancer: Exploratory Analysis of Three Radiation Therapy Oncology Group Phase 3 Studies.
Felix Feng, Branko Miladinovic, Ke Zhang, James J Dignam, Daniel Wang

Eur Urol· September 2023

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Predictors of Pneumonitis in Combined Thoracic Stereotactic Body Radiation Therapy and Immunotherapy.
Mark C Korpics, Rohan R Katipally, Julien Partouche, Dan Cutright, Kelli B Pointer, James J Dignam

Int J Radiat Oncol Biol Phys· November 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Hematuria following Post-Prostatectomy Radiotherapy: Incidence Increases with Long-Term Followup.
William Tyler Turchan, Dan Cutright, Tianming Wu, Jim X Leng, James J Dignam

J Urol· June 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Reply by Authors.
William Tyler Turchan, Dan Cutright, Tianming Wu, Jim X Leng, James J Dignam

J Urol· June 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Appropriate Systemic Therapy Dosing for Obese Adult Patients With Cancer: ASCO Guideline Update.
Jennifer J Griggs, Kari Bohlke, Edward P Balaban, James J Dignam, Evan T Hall

J Clin Oncol· June 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Statistical Considerations in the Evaluation of Continuous Biomarkers.
Mei-Yin C Polley, James J Dignam

J Nucl Med· May 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Disparities in Breast Cancer: Narrowing the Gap.
James J Dignam

J Natl Cancer Inst· April 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Validation of a 22-Gene Genomic Classifier in Patients With Recurrent Prostate Cancer: An Ancillary Study of the NRG/RTOG 9601 Randomized Clinical Trial.
Felix Y Feng, Huei-Chung Huang, Daniel E Spratt, Shuang George Zhao, Howard M Sandler, James J Dignam

JAMA Oncol· April 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis